Theranica (Series C)
Funding Details
- Awarder
- Inbox
- Date Award
- August 29, 2022
- Vertical
- Digital Therapeutics
- Funding URL
- View Funding Page
- Funding Amount:
- $45,000,000
Company Info
- Traction
- Recently surpassed a quarter of a million treatments administered to date.
- Founders
- Alon Ironi
- Company Description
- Theranica is a prescribed digital therapeutics company dedicated to creating effective, safe, affordable, low-side effect therapies for idiopathic pain conditions. The company's award-winning flagship product, Nerivio®, is the first FDA-cleared smartphone-controlled prescribed wearable device for acute treatment of migraine.
- Market
- Idiopathic Pain Conditions
- Location
- Montclair, NJ, USA
- Coinvestors
- MoonCorundum Open Innovation, Lightspeed Venture Partners, LionBird, New Rhein Healthcare Investors, Takoa Invest